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Sunscreens are ultraviolet radiation (UVR)-absorbing chemicals that attenuate the amount and
nature of UVR reaching viable cells in the skin. They are selected and tested for their ability to
prevent erythema. No sunscreen prevents photodamage, as it has been demonstrated that
suberythemal doses of UVR cause a variety of molecular changes (including DNA damage) in
these cells. Furthermore, the spectrum of UVR reaching viable cells is altered by topically applied
sunscreen. In this review, the basic aspects of sunscreens and skin photobiology are reviewed
briefly. Although there can be no question concerning the efficacy of sunscreens for the
prevention of erythema, questions remain because of the possible cumulative effects of chronic
suberythemal doses and the increased exposure of skin cells to longer UVR wavelengths. The
current major issue surrounding sunscreens involves their ability to protect skin cells against the
effects of UVA radiation. These UVA effects may be direct damage (base oxidations) or effects on
the skin immune system, yet there is no uniformly accepted method for the evaluation of UVA
protection. This review is focused primarily on the latter topic covering action spectra that implicate
the need for UVA protection. In addition, in vivo and in vitro methods proposed for the evaluation
of candidate sunscreen formulations of UVA protective ability are reviewed. Finally, revisions in the
terminology used to describe the protection afforded by sunscreens are suggested. It is proposed
that SPF ("sun" protection factor) be renamed "sunburn" protection factor and that "critical
wavelength" be designated "long wave index." Key words: critical wavelength, long wave index,
sun protection factor, sunburn protection factor, ultraviolet radiation. - Environ Health Perspect
108(suppl 11:71-78 (2000).
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Sunscreens were originally developed to
minimize erythema (1,2). However, for many
years these products provided minimal skin
protection and in fact were often referred to as
suntan lotions. The concern about the long-
term consequences ofearly childhood sunburn
experiences and their apparent correlation with
thedevelopmentofcancerlater inlifeled to the
public education campaign promoting the fre-
quent useofsunscreens in the 1980s. Thecom-
fort associated with the scientific basis ofthis
message was correlated with the known photo-
chemical effects of ultraviolet B (UVB)
(cyclopyrimidine dimer formation), which led
to the widespread acceptance ofthis message.
The impact ofthis public health message was
furthered by the newly appreciated effects of
ozone depletion on the levels ofUVB that
might reach the surface of the earth (3).
However, subsequent studies showed that these
sunscreens were not preventing other effects in
skin. Specifically, it was demonstrated in both
animal and human studies that other non-
erythemal effects were occurring as a result of
the cumulative exposure to suberythemal
amounts ofsolar radiation (4). These photoag-
ing-type effects eventually were attributed to
the UVA portion of UV radiation (UVR)
being transmitted through the sunscreen-pro-
tected skin. More recently, the possible contri-
bution ofthese transmitted wavelengths to the
development ofskin cancers has also become
more fullyappreciated.
The solar spectrum at the earth's surface is
dramatically filtered by stratospheric ozone.
The UV spectrum has been divided into three
regions: UVA, 320-400 nm; UVB, 290-320
nm; and UVC, 200-290 nm (5). These defi-
nitions date back to early part ofthis century
and were not biologically based. Rather, they
represented convenient designations based on
the transmission ofcommon optical filters in
use at that time. The UVA region has been
further divided more recently. The range
from 320 to 400 nm has been designated
UVA-II because the molecular effects induced
by these wavelengths are similar to UVB
wavelengths (i.e., causing direct DNA
damage; see next section).
UVA Effects in Skin
DNADamage
The best-characterized effects ofUVR expo-
sure are those evident in DNA. Beukers and
Berends (6) first described the photochemical
linking ofthymines after irradiating frozen
aqueous solutions with UVC radiation. Their
occurrence and repair several years later in
DNA from in vivo irradiated cells were
described by Setlow and Carrier (7).
Pyrimidine dimer formation and repair in
human skin were described by Sutherland et
al. (8). Careful experiments since then have
demonstrated a correlation between the
action spectrum for DNA damage induction
and sunburn (9). Because an action spectra
defines the relationship between some prop-
erty and the wavelengths ofradiation used to
induce the effect, it is the most informative
and probably most important of all photo-
biologic phenomena. An action spectrum for
the induction oferythema in human skin was
originallyreported early in this century (10).
OtherSkinChromophores
Although the primary chromophore of
concern in the case of UVB and UVA-II
exposure is DNA, protein components also
absorb these wavelengths, yet little in vitro or
in vivo photochemistry ofthese moieties has
been reported. In addition, longer wavelength
photons (UVA-I) may be absorbed by other
endogenous molecules that can transfer
excited-state energy to DNA, leading to
photooxidation ofselected bases [see next sec-
tion; for an introduction to basic principles of
photochemistry, see Kochevar (11)]. Other
effects may be traced to clastogenic factors
generated from other uncharacterized photo-
reactions [e.g., lipid oxidation; see Morliere et
al. (12)]. In addition, it has been suggested
that the UVA component ofsolar radiation
may inducelipidperoxidation, which can sub-
sequently stimulate the migration ofimpor-
tant immune-mediating skin resident cells
from the epidermis and thereby lead to skin
immune suppression. Furthermore, Tyrrell
and Pidoux (13) show that only40% ofcyto-
toxic effects from sunlight (290-434 nm) was
due to the UVB component. The citedstudies
also highlight the limitations oflaboratory
sources. Although these studies are convenient
and reproducible, theydo not exactly replicate
the sun; when studies using artificial sources
are compared, it is important to verify their
similarities (14). Often the same source may
have been employed (e.g., FS-40 sunlamps),
but in one case with UVC filtering and in the
other without filtering (15). Another particu-
larlygoodexample ofa comparative studywas
published recently (16). For a comprehensive
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review ofthe effects ofUVR for the general
scientific audience, see de Gruijl (17) and
Diffey (18).
APpi~roateness ofAnimalModels-
Pitals ndRemedfies
To studythe chronic effects ofUVRexposure
in skin, it has been necessary to employ ani-
mals. For the most part, mice have been
accepted as a reasonable model for human
skin response to UVR exposure. Chronic
exposure ofmurine skin to UVR leads to the
development ofone type ofskin cancer, squa-
mous cell carcinoma (SCC) (19). In human
skin, in addition to SCC, basal cell carcinoma
(BCC) and malignant melanoma (MM) are
commonly found and thought to be induced
by chronic solar exposure (20). However,
because there has been little success in devel-
opment of convenient animal models for
these malignancies, precise animal studies to
explore dose and wavelength dependencies
have not been performed. An opossum model
has been used for the study of UVR induc-
tion ofmelanoma. Studies in this system sug-
gest that portions ofthe UVA spectrum may
play a significant role in the development of
melanoma (21,22).
Mice commonly employed for skin
photobiology studies have few melanocytes in
the skin areas exposed to UVR. However,
there are some interesting new models on the
horizon. In an attempt to create a human skin
model system for laboratory studies, Attilasoy
et al. described the induction ofmelanocytic
lesions in human foreskins transplanted to the
backs ofscid mice (23). One melanoma and
several melanocytic lesions were found in the
grafted skin. In the group of mice who
received only UVB (3x per week for up to 12
months), 23% ofthe skin grafts developed
solar lentigines in 5-10 months. When the
UVB regimen was preceded by a single appli-
cation ofdimethylbenz[a]anthracene, the fre-
quency increased to 38%. The sole melanoma
was found in the latter group ofmice. In these
studies the UVR source employed emitted
radiation primarily in the UVC and UVB
regions. The amount of UVA in the source
was small compared to that found in natural
sunlight, thus these studies represent a single
point in an action spectrum for the induction
ofmelanocytic lesions (24).
Mintz and Silvers have described the
development ofmelanoma in a transgenic
murine model (Tyr-SV4OE) with melanoma
susceptibility (25). Different inbred lines are
susceptible to different extents. In moderately
susceptible mice, melanomas could be
induced after four successive daily exposures
to UVB radiation. Although it has been sug-
gested that these mice could be used to deter-
mine an action spectrum for melanoma
induction, more recent studies have examined
nine different protocols for the induction of
melanoma. The highest incidence of
melanoma (five melanomas in 19 mice) was
found using a protocol in which the mice
were exposed to 0.38 J/cm2 UVB/day for 5
days starting at 3 days ofage (26).
Another transgenic mouse with melano-
cytes residing in many anatomical areas has
been described recently (27). The epidermis
ofthese transgenic mice, bearing a keratin 14
promoter-driven modified cDNA for stem
cell factor (the ligand ofthe kit receptor, tyro-
sine kinase), have keratinocytes that continue
to express stem cell factors beyond the neona-
tal period, resulting in the maintenance ofa
population ofpigment-producing melano-
cytes in the skin throughout their lifetime.
These mice develop postinflammatory hyper-
pigmentation in response to irritant and aller-
gic contactants. Whether these could be a
candidate animal model for the study ofthe
action spectrum for the induction of MM
remains to be determined. Others have sug-
gested replacing animal studies with human
skin equivalents (28). However, it remains to
be determined how relevant such a system
can be. Its utility may be limited to develop-
ing techniques for the eventual application to
in vivophotochemistry.
Application ofMurine Datato the
Evaluation ofHuman Skin CancerRisk
The carefully determined murine action
spectrum for SCC has been mathematically
adjusted to account for human skin parame-
ters (29). It is from these data that we can
infer with a high degree ofconfidence that
screening UVB radiation may attenuate the
development of SCC in human skin (30).
Furthermore, although limited, there are
actual human experimental data. Thompson
et al. have shown that the regular use of a
high potency sunscreen (sun protection factor
[SPF]-17 containing both UVB and UVA
absorbing ingredients) could prevent solar
keratoses (31). These results imply the possi-
bility that by preventing keratoses, skin
cancers may be prevented as well.
SynergisticEffects ofUVBandUVA
Possible interactions between UVB and UVA
have not been extensively tested (not even
indirectly), as primarily UVB-rich sources
have been employed for laboratory studies.
However, human skin is rarely exposed to iso-
lated regions of the UV spectrum (32).
Chung and Youn demonstrated that UVB
increased the production ofinterleukin(IL)-1,
whereas UVA suppressed it (33). UVA also
suppressed the UVB induction of the
cytokine. However, a more recent study using
human volunteers demonstrated no correla-
tion between UVA pre-exposure and the
development ofUVB-induced erythema (34).
Pigmentation Effects
Exposure ofhuman skin also leads to darken-
ing effects, the extent ofwhich depends on
individual skin type (35). Immediate pigment
darkening (IPD), likelythe result ofphoto-oxi-
dation processes, can be observedwith minutes
ofsolar exposure (36). In contrast, delayed
pigment darkening occurs over a somewhat
longer time period. Although the former offers
little if any skin protection against solar radia-
tion, the latter effect is derived from the pro-
duction ofmelanin as an adaptive, protective
response against further UVR damage. In
addition to different kinetics and protective
effects, the action spectra for their induction
may differ. The maximum wavelength for the
induction of IPD is approximately 340 nm
(36), whereas delayed pigmentation parallels
the erythema action spectrum. In other
studies, it has been shown that pigmentation
effects are also accompanied byvaryingdegrees
ofepidermal thickening (37), so that even
individuals who develop little pigmentation as
a result of sun exposure can develop some lim-
ited UVR tolerance. This is not meant to
encourage UVR exposure in these individuals
but rather to emphasize the complexities ofthe
response ofhuman skin to UVR
IsSkin Pigmentation Protective*
The answer to this question is not a simple
one. The significant differences in the inci-
dences of all skin cancers in blacks versus
Caucasians strongly suggest a protective effect
from pigmentation (38). The tan acquired by
overly exposed Caucasian skin also offers
some protection from erythema (39).
Whether this same level ofpigmentation also
protects skin from cancer has been the subject
of some debate. In a recent report Lock-
Andersen et al. measured constitutive and fac-
ultative skin pigmentation in Caucasians with
BCC and cutaneous malignant melanoma
(CMM) (40). Although theyexpected to find
that constitutive skin pigmentation would be
lower in these patients, they were surprised to
find neither a statistical difference between
patients and controls nor any difference
between CMM and BCC patients. These
observations suggest that factors other than
pigmentation may be important in skin
cancer etiology. Among these possible factors
are reduced skin repair capacity in fair-
skinned subjects and possibly the presence of
a higher proportion of the less protective
pheomelanin (rather than eumelanin).
Regarding the former, D'Errico et al. quanti-
fied DNA repair capacity (DRC) in 49
patients with BCC and 68 cancer-free con-
trols (41). A statistically significant age-
related decline in DRC was observed in the
control group but not the BCC group. When
comparisons were made on the basis of age, it
Environmental Health Perspectives * Vol 108, Supplement 1 * March 2000 72SUNSCREENS, SKIN PHOTOBIOLOGY, AND SKIN CANCER
was shown that young BCC cases (less than
40 years ofage) repaired less than the controls
but without statistical significance. Older
BCC patients (more than 40 years ofage)
demonstrated enhanced DRC (p < 0.0001).
In other kinds ofinternal cancers, it had been
demonstrated that a mean DRC in the range
of65-95% ofthe general population is usu-
ally more frequent in the cancer cohorts.
However, transient effects on DRC may be a
confounding factor. Among these are recent
exposures to UVR itself. The role ofDRC in
the potential evaluation or the development of
skin cancer needs furtherstudy.
The answer to the title question for
medium and darker skin types may be more
complicated. For the most part it appears that
outdoor workers become acclimated to sun
exposure by a variety ofmechanisms (42). In
fact, most skin adapts to chronic (not neces-
sarily excessive) sun exposure. Recent skin
cancer statistics indicate that skin cancers of
any kind were found in less than 15% ofa
screened population (43). Certainly many of
the 85% without skin cancers may have
avoided sun (at least in their adult years), yet
many (most likely the vast majority) have
probably spent considerable time in the sun
during their lifetimes.
In recent years an entire industry has
grown up around the concept ofacquiring
and/or maintaining tanned skin by exposure
to artificial sources ofUVA. There is limited
data indicating any long-term ill outcome in
terms ofskin cancer, although there is evi-
dence ofsignificant actinic-type damage (44).
Almost certainly excessive tanning will lead to
photoaged skin in these frequent tanners. In
addition an unknown percentage will have an
increased incidence ofskin cancers. However,
it will not be a simple task to deconvolute the
relative contributions ofnatural solar exposure
and artificial tanning. However, actual data
are not available at this time to determine
whether the incidence ofskin cancer in artifi-
cial tanners will besignificantly greater than in
the general population and the extent to
which artificial tanningmade acontribution.
MolecularChanges inUVR-Exposed
Skin
The time-dependent gross physiologic
changes described above are accompanied by
more subtle molecular changes, invisible to
the eye, that are the initiating events for the
long-term detrimental effects ofsolar expo-
sure. For example, in physiologically normal
skin, clonal subpopulations ofcells can be
found that harbor p53 mutations (45). These
occur much less frequently in sun-shielded
skin. In sun-exposed skin these kinds ofpop-
ulations are not only more frequent but also
larger in size. These p53-harboring cells
appearing in normal skin are derived from
earlier exposures to UVR, perhaps and most
likely dating as far back as childhood. Every
UVR exposure from the earliest years of
childhood has the potential to induce new
DNA photoproducts and their concomitant
downstream effects. Human skin, to varying
degrees depending on genetic makeup and
general health status, possesses the capacity to
repair these photoproducts. However, some
may be unrepaired or misrepaired and hence
lead to mutations. In individuals with geneti-
cally compromised DNA repair capacity
(xeroderma pigmentosum patients), the lack
ofefficient repair leads to numerous skin can-
cers early in life (second decade) (46).
Multiple skin cancers also occur in transplant
patients who receive systemic immune-sup-
pressive agents (47,48). Although there
appears to be some controversy about the eti-
ologic origin ofthese skin cancers, a recent
analysis ofp53 mutations in SCC from renal
transplant recipients strongly implicates a role
forprior UVRexposure (49).
p53 InductionandMutations in
PhysiologicallyNonnalSkin
andSkinCancers
The morphology of "sunburn" cells was
originally described by Daniels et al. (50).
Eventually it was shown that these were
photodamaged cells in the process ofundergo-
ing apoptotic cell death. Apoptosis in skin
cells exposed to UVR has also been correlated
with the induction ofp53. Because ofits role
in growth arrest and tumor suppression, p53
has been investigated as a surrogate marker in
skin for the deleterious effects ofUVR expo-
sure. Ponten et al., for example, have shown
that sunscreen application attenuated the
induction ofp53 after UVRexposure (51).
Using an allele-specific assay, Anantha-
swamy et al. have demonstrated the ability of
sunscreens to prevent some UVR-specific
mutations in murine skin. In first of these
studies a UVB source was employed, and
hence the ability ofa potent UVB sunscreen
to reduce the frequency ofmutations was not
surprising (52). In a follow-up study similar
findings were reported when a solar simulator
was employed (53). Yet even further studies
will be required to determine if mutations
derived from indirect photosensitized reac-
tions caused by long wavelength UVR pho-
tons (and possibly short wavelength visible
light, neither ofwhich is present in most
solar-simulating light sources) are also pre-
vented. As mentioned above, LeVee et al.
(14) showed that solar simulators are
typically devoid oflonger UVAwavelengths.
ImmuneSuppression
Cells containing DNA damage that escapes
faithful repair can be kept from proliferating
by the skin immune system (54). However,
exposure of skin to immune-suppressive
agents (as in cardiac and renal transplant
recipients) can lead to the development of
large numbers ofskin cancers. Sun exposure
also suppresses skin immune surveillance.
Once again, a detailed action spectrum for
this immune suppression in human skin is
not known. However, it has been repeatedly
demonstrated that no sunscreen protects
skin immune function as well as it protects
skin from erythema (55). One recent paper
made claim that some sunscreens protected
the immune system to an extent that
exceeded their label SPFs (56). However, a
careful review revealed a flaw in the data
analysis. The corrected analysis showed that
the best of the sunscreens could only pro-
vide approximately 50% oftheir SPF values
for immune protection (57). Thus, it can
be safely assumed that a portion of the
action spectrum for solar immune suppres-
sion lies beyond the UVB region and in the
UVA region (58). How far into the UVA
spectrum skin needs to be protected to pre-
vent immune suppression is unknown at
this time.
The critical role ofimmune suppression
in skin cancer is buttressed by at least two
observations. First, as described above, it is
common for actinic keratosis to sponta-
neously regress, which suggests the involve-
ment of an immune-mediated mechanism
(59). Second, Colombo et al. have
described the coexistence of regions of
regression and progression in melanoma
lesions (60). In addition, Wagner et al. have
demonstrated that the immune response
against human melanomas involves a distinct
cytokine pattern (expression ofgranulocyte
macrophage-colony-stimulating factor,
IL-12, and IL-15) that is associated with
spontaneous regression (61). When these
results are considered with those ofWolfet
al., who showed that UVB-type sunscreens
do not prevent the progression of trans-
planted melanomas, the importance of
broad spectrum UV protection is empha-
sized (62). These kinds of data raise the
question ofwhether partial protection ofthe
skin immune system by current sunscreen
products is at least minimally adequate. In
addition, once again they strongly suggest
different wavelengths are responsible for dif-
ferent effects in skin (e.g., sunburn vs skin
cancer vs immune suppression).
Elmets et al. have shown a close correla-
tion between the action spectra for photo-
product formation and the induction of
immunologic unresponsiveness of murine
skin to dinitrofluorobenzene after exposure to
low-dose UVR (63). DeFabo and Noonan
showed a partial correlation ofUV-induced
cis-trans isomerization of urocanic acid with
immune suppression (64).
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Immune suppression has been shown to be
related directly to DNA photoproduct forma-
tion. Studies in which immune suppression
was assessed after the photoreversal or enzy-
matic removal ofpyrimidine dimers showed a
partial restoration ofimmune function (65).
However, an action spectrum forthis effect has
not been reported. Whether these effects are
limited to the formation ofpyrimidine dimers
or whether the induction ofbase oxidation
processes caused by longer UVA wavelengths
could also lead to skin immune suppression is
unknown. Further complicating the issue of
action spectra, Kim et al. reported that the
suppression ofdelayed and contact hypersensi-
tivity responses demonstrated different UV
dose responses, suggesting different underlying
biologic mechanisms (66). Similar findings
would be expected in human skin. These lim-
ited studies suggest that the multitude of
immune events could have different action
spectra so that selecting any one as a surrogate
marker for the immune-protective assay of
sunscreens could be short-sighted and
potentially misleading (67).
Finally, these data suggest that immune
toxic effects may play a stronger role than
previously appreciated in the development
of melanoma. It is widely appreciated that
SCC is common in immune-suppressed
transplant recipients; there are similar data
for premalignant melanocytic lesions (68).
These data make it even more urgent to
determine immune-suppressive action
spectra in human skin.
Although it is common to assume there is
a relationship between skin cancers and sun
exposure, it is important to note the different
correlations for anatomic locations ofdiffer-
ent kinds ofskin cancer. There is a strong
correlation between sun exposure and SCC
but a somewhat weaker association for BCC
and MM (69). Analyses ofSCC and BCC
Table 1. FDA-approved sunscreen ingredients and
maximum concentrations.a
Max
Ingredient
Aminobenzoic acid
Avobenzone
Cinoxate
Dioxybenzone
Homosalate
Menthyl anthranilate
Octocrylene
Octyl methoxycinnamate
Octyl salicylate
Oxybenzone
Padimate-0
Phenylbenzimidazole sulfonic acid
Sulisobenzone
Titanium dioxide
Trolamine salicylate
Zinc oxide
ximum concentration
(%l
15
3
3
3
15
5
10
7.5
5
6
8
4
10
25
12
25
demonstrate the signature effect of UVR as
characteristic p53 mutations (70). However,
when MM are examined, the incidence of
p53 mutation is lower, late arising, and not
conclusively implicative of UVR exposure
[see Zerp et al. (71) and references therein].
Action Spectrum forPhotoelastosis
Actinic damage without skin cancer can result
from occupational or recreational activities.
The skin becomes wrinkled, leathery, andvari-
ously pigmented. Ifthis aged skin is compared
to unexposed buttock skin, differences in the
organization ofcollagen and elastin can be
readilyobserved (72). These may be a result of
direct photochemical modifications ofthe pro-
teins or perhaps posttranslational effects.
Regarding an action spectrum for these effects,
conflicting results have been published.
Kligman and Sayre reported a photoelastosis
action spectrum very similar to that for
erythema (primarily UVB dependent) (73).
However, other reports showed a much greater
contribution in the UVAregion [see Sayre and
Kligman (74) and references therein]. These
different results have been attributed to thedif-
ferent methods used to assess photoaging and
possibly to straylighteffects (73).
Sunscreens
Sunscreens have been developed and tested
by the industry and approved by the U.S.
Food and Drug Administration (FDA) on
the basis oftheir ability to prevent erythema
(see Table 1 for list of approved ingredi-
ents). Using the FDA-approved SPF number
as a guideline, a consumer can select a prod-
uct to comfortably extend the time spent
exposed to solar radiation without the risk of
developing a sunburn. Although sunscreens
are not recommended for this purpose, for
all practical purposes their application
ensures that the user is likely to spend more
time in the sun than ifthe product were not
employed. If the same wavelengths respon-
sible for sunburn also caused the other dele-
terious effects in skin, this would not
present a problem. However, as cited above,
evidence is mounting to implicate contribu-
tions from other portions of the solar spec-
trum in skin cancer and photoaging. Hence
there has been a significant effort to develop
broader spectrum protection by adding UV-
absorbing chemicals with UVA absorbency
to sunscreens.
The high level offamiliarity and public
acceptance of SPF labeling are indicative of
the success of an education campaign that
began in the 1980s. Although some advocate
a simplistic message about informative label-
ing of sunscreen products and public educa-
tion messages about sun exposure and skin
cancer, the success of the SPF program
should encourage the development of a
factual approach to development of a
comprehensive public health message for sun
safety. Thus, as opposed to a "dumbing
down" approach, consumers should be pre-
sented with a scientifically accurate informa-
tion package. The danger ofdumbing down
is indicated by a recent report. McCarthy et
al. surveyed beachgoers in Galveston, Texas,
and found that those who employed higher
SPF sunscreens had a greater incidence of
sunburn and spent more time in the sun
(75). In addition it is time to recognize that
some individuals may tolerate much more
sun than others (76). This tolerance may be
based on genetic makeup or tolerance devel-
oped over years ofsolar exposure. It is doubt-
ful that an era can be rationally anticipated
when people will not want to participate in
outdoor activities despite the scare tactics
currently in vogue (77).
Sunless Tanning
There has been some modest success in
developing agents that cause skin pigmenta-
tion without the need for UVR exposure.
Among these, dihydroxyacetone (DHA) has
been available for many years (78). Although
darkening ofskin color is produced by DHA,
it offers little protection to the underlying
cells; hence excessive solar exposure must be
avoided. Chemicals that can stimulate tyrosi-
nase, an important intermediary ofmelanin
synthesis, have also been incorporated in
some topical products. These different agents,
L-dopa (79), dinucleotides (80), and diols
(81), may interact with different pathways of
the melanogenesis system. For all ofthese
products there are some issues that remain to
be addressed. At this time it is not clear
whether any long-term effects will arise,
either with product use alone or combined
with UVR exposure. Other issues are the lev-
els of sun protection and the extent of this
protection. The foregoing questions also
apply to soluble synthetic forms ofmelanin
that can be applied topically (82).
Another side ofthe melanin question has
been addressed recently. Moan et al. have
presented a novel hypothesis for melanoma
induction (83). Specifically, it was suggested
that melanin could act simultaneously as a
photoprotective agent as well as an intermedi-
ary in photocarcinogenesis. The effect derived
from the absorption of UVR by melanin
would be related to its physiologic location.
Melanin in the upper layers ofskin would be
photoprotective, but melanin in melanocytes
could be photocarcinogenic. For direct exper-
imental evidence for melanin-mediated dam-
age, see Marrot et al. (84). The preceding
two papers address one side ofthe question
presented by Wood et al. (85) ("What's the
use ofgenerating melanin?"). In support of
their hypothesis, Moan et al. cite statistics for
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the induction of SCC, BCC, and MM in
different countries at various latitudes (86).
Beneficial Effects ofUVRExposure
Exposure ofskin cells to UVR is essential for
the production ofvitamin D (87). However,
the necessary amounts ofUVR needed are
quite small and can be obtained by the expo-
sureofhands and face to afew minutes ofsun-
light even in winter. In contrast, some have
daimed that the use of sunscreens may unnec-
essarily suppress the production ofvitamin D
and lead to development ofinternal malignan-
cies like colon and breast cancers (88). Others
have reported that the general sense ofwell-
being after sun exposure can be attributed to
the induction ofendorphins (89).
Epidemiologic Considerations
Epidemiology studies can relate human
diseases to their causes. Excessive sun expo-
sure, light complexion, and proximity to the
equator have all been conclusively associated
with an increased risk ofskin cancer (90).
The epidemiologic picture for the relation-
ship between sunscreen use and skin cancer
development is much less clear. As counter-
intuitive as this may appear, several studies
have demonstrated a correlation of skin
cancer with sunscreen use (91). Attempts to
attribute these findings to weak sunscreens or
improper use of potent sunscreens may be
missing the mark. For the most part sun-
screens have been and continue to be selective
filters ofsolar UVR. Historically most have
been very good UVB absorbers, hence their
efficacy for the prevention of sunburn and
possibly actinic keratosis and SCC. However,
a sunscreen that filters UVB efficiently may
permit the underlying cells to be exposed to
greater amounts of the UVA portion ofthe
solar spectrum. Sunscreen users are warned
about using these products to extend their
time in the sun. However, without a sun-
screen or a somewhat protective tan, the aver-
age Caucasian would not be able to tolerate
much more than approximately 10-20 min
in the summer noonday sun without accu-
mulating sufficient damage that would even-
tually lead to mild erythema. With proper
application of an SPF-15 sunscreen, pro-
tected skin would not experience any ery-
thema for several hours, yet would be exposed
to all ofthe UVR wavelengths not absorbed
by the sunscreen (92). Furthermore, the
physiologic changes that occur during UVA
erythema are not the same as those caused by
sunburn (93,94).
Sunscreen Substantivity-Durability
andPhotostability Issues
For years substantivity has been used to refer
to the ability of a sunscreen to resist washing
off during swimming or sweating offduring
vigorous exercise. The recently released final
FDA monograph (95) on sunscreen revised
these definitions (Table 2). More recently,
photosubstantivity issues have been raised,
primarily regarding avobenzone. Sayre and
Dowdy used an in vitro testing method to
show that the exposure of avobenzone to
physiologic doses ofUVA led to its photo-
degradation (96). These studies are novel for
two reasons. First, the authors did not assume
that the only photochemistry would occur as
a result of irradiation at the maximal wave-
length ofabsorption. Second, they employed
a modified solar simulator that more accu-
rately reflects the UVA component ofsun-
light UVR. Solar simulators typically lack the
longer wavelength region ofthe UVA sun-
light spectrum. The UVA doses to which
avobenzone was exposed ranged from 1 to 10
MEDs. In studies using actual sunscreen
products, it was also shown that the UVA-
induced photodegradation of avobenzone
could also lead to the decomposition ofnor-
mally stable UVB screening agents such as
octylmethoxycinnamate and padimate-O.
Recently it has been shown that the pho-
todegradation ofavobenzone could be pre-
vented by formulating products with
avobenzone and octocrylene (advertisement
for Umbrelle). The triplet-state energies of
these two molecules lie close enough to allow
the transfer from avobenzone to octocrylene,
thereby leading to avobenzone photostability.
Yet these studies highlight the need to evalu-
ate photochemistry, not only in sunscreen
candidate molecules but also in the actual
products as theywould be formulated for sale
to consumers.
Critical UVA Issues
Although sunscreens are highly efficacious
for their ability to block the UVB portion of
the solar spectrum, a critical issue that
remains unresolved is their ability to screen
UVA. The problem regarding UVA is 2-fold.
First, detailed action spectra for biologic
effects in human skin extending through the
UVA do not exist. Second, there is no man-
dated regulation detailing how to test a prod-
uct for UVAefficacy. Clearly these two issues
are intertwined. The lack of data for the
above can explain the omission ofany direc-
tives on UVA in the recently issued final
FDA monograph (97).
UVAProtection in CurrentProducts
Rosenstein et al. have compared in vitro
transmission spectra with SPF label specifica-
tions for 11 sunscreen products (98). Six of
these products had labels claiming UVA pro-
tection. Spectrophotometric data for each
product were convoluted with the
International Commission on Illumination
erythema action spectrum and the sunlight
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Table 2. Summary of FDA sunscreen regulations and
terminology.a
*The FDA has established 30 as an upper limitfor SPF
labeling. Products with SPFvalues over 30 may be
labeled as "30 plus" or "30+`b
*The SPF value for a product labeled "water resistant"
or "very water resistant" will be the SPF determined
in the water resistance test
*Extended wear claims concerning a specific number of
hours of protection and the use ofterms such as "all
day protection" are not permitted
*Permissible labeling is limited to prevention of sunburn
SPF, sun protection factor. &See Federal Register (95). bNote
added in proof: an industry petition has resulted in an extension
ofthis deadline to 21 May 2001.
spectrum determined for solar noon, thereby
producing effectiveness spectra for each
product. Products claiming UVA protection
had effectiveness levels ranging from 6 to
52% (measured from 320 to 400 nm).
Especially noteworthy findings in this study
are a) the different products varied widely;
b) a product containing only TiO2 claiming
an SPF factor of 17 with no UVA claim pro-
vided the greatest degree ofUVA screening,
whereas another product with a prominent
claim for UVA protection screened less than
half of UVA wavelengths; c) two products
with excellent UVA screening properties
contained one of two strong UVA
absorbers-parsol 1789 and mexoryl SX.
The latter is not available in the United
States, and the former has been the subject of
some discussion regarding its photostability.
HowFarinto UVA.?
This question cannot be answered with any
degree ofcertainty until more action spectra
studies are performed. Preliminary studies
employing mice may be appropriate, but it is
important to recognize that murine and
human skin differ significantly in their cellu-
lar composition, structure, and responses to
UVR (99). Action spectra studies should
examine UVA-induced molecular effects in
human skin. For example, in vitro studies
show that the action spectrum for the induc-
tion of 8-hydroxyguanine extends into the
visible region of the spectrum (100). The
effects ofUVA wavelengths on cytokine pro-
files should be performed. Because of the
deeper penetration ofUVA radiation (inverse
relationship with wavelength), larger numbers
ofviable cells maypotentially be affected.
EvaluationofUVAProtection
Two kinds of measurements have been
suggested to characterize the UVA protective
ability ofsunscreens. In principle, as with
UVB, erythema development could be
employed. However, this is not a practical
test when the times required to deliver the
necessary UVA doses with and without sun-
screen protection are considered. Two
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different pigmentation effects, immediate and
delayed, have also been suggested as measures
ofskin exposure to UVA in humans. Each
has distinct advantages anddisadvantages.
The advantage of IPD is that it occurs
relatively early after UVA exposure.
However, there is significant interindividual
variability, which detracts from its routine
use, and its action spectrum peaks at shorter
wavelengths ofthe UVA region. Additonally,
IPD is not photoprotective and hence serves
no physiologic function (101).
Delayed pigmentation occurs over a much
longer time frame but is more predictable,
and might be preferred ifthe lag time were
not so long. At this time there is no practical
biologic end point known to act as a surro-
gate for photocarcinogenesis or photoaging.
With additional action spectrum studies in
the UVA region, a molecular marker for
UVAexposure might bedeveloped.
It has also been proposed that the well-
characterized ability of8-methoxypsoralen to
sensitize skin to UVA be employed to test
candidate products for their UVA screening
ability (photosensitization protection factor)
(102). However, it is unlikely that the
psoralen action spectrum in skin will match
all (ifany) of the UVA-induced effects in
nonsensitized human skin.
Considering the current need for broad
spectrum UVB/UVA sunscreen products and
the absence ofa meaningful and clinically
viable biologic marker, it would seem best to
characterize that the sunscreen attenuates
radiation in the spectral region thought to be
harmful to skin cells. An in vitro instrumental
method that characterizes the UVA screening
ability of a sunscreen product has been
described (103). A problem with this
approach is the infinite variety ofspectral
shapes and the inability to easily compare
products with different absorption spectra. A
solution to theproblem has been proposed by
Diffey (104). By arbitrarily selecting the
wavelength at which 10% of a sunscreen
product absorbance falls, the so-called critical
wavelength (CW) is defined. The term criti-
cal has met with some criticism. Perhaps a
better description would be spectral screening
factor and/or long wave index (LWI). The
proponents ofthe CW method stress its sim-
plicity, reproducibility, and ability to account
for photosubstantivity issues. On the other
hand, critics cite its lack ofhuman relevance
because it is an in vitro test where no biologic
end point is measured. Although some have
questioned the biologic relevance of CW
analyses (i.e., no animal or human test sub-
ject), this concern may be a red herring. An
ideal sunscreen product should function as a
pure screening agent. Hence a method that
analyzes its raw screening ability may be the
most appropriate method. To avoid the
judgmental tone ofCW, here it is proposed
that this index be renamed the LWI. Thus,
the greater the LWI (Table 3), the further
into the UVA spectrum a product's screening
potential would extend. By comparing the
LWI for different sunscreens, the consumer
could assess the extent ofpotential protection
offered by different products. The LWI is
based on an instrumental method, which
avoids any complications from idiosyncratic
biologic variations from individual to individ-
ual. This technique is also reproducible and
fast. In addition, the products can be pre-
exposed to solar radiation to detect changes
in LWI caused by photochemical degrada-
tion or instability (105). Because there is no
need for human volunteers, it would be rela-
tively inexpensive. Finally, using the LWI
would eliminate the need to select from the
wide range of skin biologic processes that
may be affected by exposure to UVR.
Considering the potentially different action
spectra, this would solve the major quandary
ofwhich of these should be selected as the
index for determining UVAprotection.
Practical AspectsofSunscreens
Sunscreens should be user friendly, with easy-
to-understand directions about their proper
and efficacious use. In mid-1999 no sunscreen
product provided exact instructions on the
amount ofproduct to be applied to skin. This
is important because studies have shown that
much less than the effective SPF amount is
typically applied by the user (106,107). The
reason for underapplication ofsunscreens is
clear. Although the FDA-approved testing
method requires the application of2 mg/cm2
to obtain the SPF claimed, nowhere on any
Table 3. Long-wave index-definition and examples.a
Wavelength LWI
range (nm) ratingb Examplec
<320 0 para-Aminobenzoic acid
321-340 1 Octyimethoxycinnanmate
341-360 2 Octocrylene
361-380 3 None in monograph-TiO2?
381-400 4 Avobenzone, ZnO
>400 5 None in monograph
'According to Diffey (104), the sunscreen absorbance spectrum
is reduced to a single index by determining the wavelength
where the area under the spectrum from 290 to ILwi is 90% of
the total. Here a 0-5 point scale is proposed to classifythe prod-
ucts (see Figure 1 for an example). tbo account for idiosyncratic
physiologic effects, reflectance spectrophotometry could be used
to determine LWI after sunscreens have been applied to human
skin (112). Using this system would add a second rating to the
sunscreen label. The primary number should remain the SPF
value, which could appear in bold. The LWI would appear in
parentheses or as a subscript. Alternatively, LWI could be given
in Roman numerals. Possible examples: 30 (3), 303, 30-111. An
informative label would explain this new labeling system and
would also emphasize that the LWI is not a substitute for SPF.
C[WI is meant to rate formulated sunscreen products, not indi-
vidual ingredients. These examples are cited to illustrate the
possible variations among the FDA-approved ingredients.
sunscreen product are users advised the quan-
tity ofsunscreen thatshouldbeapplied to pro-
tect their skin. Statements such as "apply
liberally and frequently" give no guidance. For
the average adultapplying sunscreen, a quarter
ofa4-ozbottleshould be used. Perhaps bottles
could come with a viewable "contents remain-
ing" window gauge to assist the consumer.
These studies also show that SPF does not fall
offlinearly with the amountappliedbut rather
approaches the square. Hence, applying half
the recommended amount ofan SPF product
would reduce the efficacy not by approxi-
mately 2-fold but by something closer to
approximately 4-fold. The FDA-mandated
SPF determination requires product applica-
tion on the skin at adensityof2 mg/cm2. The
typical adult has nearly 2 m2 ofskin. This
application rate translates into 40,000 mg or
40 g ofproduct. Thus, total coverage of an
adult at the beachwould require more than an
ounce ofproduct or a quarter ofa 4-oz bottle
for asingleapplication. Ifthe person bathed in
an ocean or pool, re-application would con-
sume another ounce. Furthermore, for the
typical family offour on a beach vacation, a
single bottle would be a day's supply. Ifthe
vacation were for a week or so, to be ade-
quately protected during their vacation they
would need to purchase a 6-pack of
sunscreen products.
ProgressiveWarning bed
Currently sunscreen products may contain a
labelstating that thefrequent useoftheprod-
uct may prevent sundamage such asphotoag-
ing and skin cancer (108). Yet these
statements were promulgated in an era when
much less was known about all ofthe effects
ofsunlight on skin biology. Given our new
appreciation ofthe complex nature ofskin
cancer, the involvement ofimmune suppres-
sion, and the role oflonger wavelengths of
solar radiation in these processes, it would
seem that such statements need to modified
m 1.20
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Figure 1. Long-wave index for a typical sunscreen. The
UV spectrum is recorded from 290 nm (the shortest
wavelength of UV radiation to which human skin is
exposed). The point that demarcates 10% of the area
under the absorption spectrum is used to define the
long-wave index(arrow; see also Table 3).
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drastically. In fact, all a label can saywith any
confidence is that the use ofthis product will
prevent sunburn if used appropriately. One
product that is commercially available con-
tains the following statement: ". . with sun-
screen protection, UV exposure can still lead
to skin cancer and premature aging, even if
you don't burn." (109).
Tomorrow's Sunscreens
More research in skin photobiology will lead
to better sunscreen products. It also appears
that educational campaigns to make individu-
als aware ofskin cancer-inducing practices
and safe sun exposure practices and protec-
tion methods are having an impact on skin
cancer incidence and detection. In the future,
sunscreen product labels need to provide the
consumer with more information, ranging
from clear factual statements about the
amount that needs to be applied to what sun-
screens can and cannot do. As labeled now,
most sunscreens products are confusing to the
average user. Statements such as "apply liber-
ally and frequently" are too vague to be infor-
mative. Others such as "do not use to extend
time spent in the sun" are counterintuitive.
Finally, the meaning of the acronym SPF
should be changed from sun protection factor
to sunburn protection factor to avoid giving
the consumer an impression ofsolar invinci-
bility and a false sense of security. SPF
defined as sun protection factor connotes an
impervious armor protecting against all
assaults on skin biology. There likely never is
to be anysuch product.
Adequate UVA protection and an
appropriate testing method of UVA efficacy
are the most pressing unmet needs. Although
some in vivo biologic method would appear
desirable, at present there is scarce biologic
data for such an assessment. In vitro testing of
sunscreens to determine the LWI can provide
additional independent information relevant
to the UVR screening contribution of
sunscreen formulations in the UVA region.
A last crucial factor beyond the scope of
this review concerns behavior modification.
The consumer needs to appreciate the poten-
tially detrimental consequences ofsunbathing
and tanning parlor usage. In summary we see
that sunscreens are efficacious for the preven-
tion ofsunburn-the reason for which they
have been designed and implemented.
Although some have promoted daily use for
the prevention ofpremature aging ofthe skin
and the prevention ofskin cancer, actual data
are lacking to support these recommenda-
tions. Furthermore, the widespread imple-
mentation ofsuch a recommendation could
lead to increased chronic exposure to solar
wavelengths not filtered by the sunscreens.
Without shorter wavelengths to serve either
as a early signal for induced photodamage or
perhaps as a triggering event for skin adapta-
tion, other events less likely to occur in full-
spectrum solar-exposed skin could take place
(110). The status ofsun protection programs
was reviewed by Geller (111). Factors
involved in sunscreen use (peer attitudes, level
ofeducation, etc.) were discussed, as well as
venues for the dissemination of sun
protection information.
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